Archived research. Equity forecasting is part of the Runchey Research archive (methodology era 1) and is no longer actively updated. Everything remains published at its original URL. Browse the archive
Will EQPT file its Q1 2026 10-Q on time with no material weakness disclosure?
Current Prediction
Why This Question Matters
First 10-Q filing under public-company timeline is the cleanest test of disclosure-control maturity flagged by Prospectus Probe (no auditor ICFR attestation in first 10-K). A clean Q1 10-Q with no material weakness disclosure validates the GOVERNANCE_ALIGNMENT=MIXED assessment leaning constructive. A late filing or material weakness disclosure would push GOVERNANCE_ALIGNMENT toward UNCONSTRUCTIVE and ASSUMPTION_FRAGILITY higher.
Prediction Distribution
Individual Predictions(9 runs)
Base rate clean+on-time first 10-Q: ~78-85%. EQPT filed FY 2025 10-K on time, KPMG signed off, no material litigation. Issuer-specific risks: first-year ICFR self-assessment without auditor attestation + KPMG critical audit matter on sale-leaseback. Risks discount baseline by ~5-10pp. ~78%.
Mgmt narrative incentive is acute (capital structure depends on continued debt-market access). Public-company finance team in place. CFO open-market purchase signals confidence. Sale-leaseback restatement is separate event (3-7% probability), not first-10-Q-specific. Per-10-Q late-filing alone ~5%, material weakness ~3%. Combined NO probability ~20%. ~80%.
Construction-equipment SaaS-style accounting complexity (sale-leaseback, OWN Program, finance leases) elevates first-10-Q risk above simple-business issuers. First-year-public companies have ~12-18% rate of late filings or material restatements within first 12 months — Q1 is biggest single-event exposure within that. Lean modestly below baseline. ~76%.
78-85% baseline cleanness for newly public companies; EQPT is in baseline range with mild downside from accounting complexity (sale-leaseback critical audit matter). Mgmt incentive strong but ICFR transition relief is a residual risk. ~77%.
Q1 deadline is May 14, 2026 (~3 weeks). EQPT 10-K filing pattern shows discipline. KPMG critical audit matter is disclosed risk; restatement is a separate market. Probability of clean filing benefits from short window for material weakness emergence at Q1 vs annual scrutiny. ~81%.
Q1 10-Q is the first stress test of public-company controls. Newly-public issuers tend to surface refinements and segment reclassifications in first quarterly disclosures. Material weakness specifically (per resolution criteria) is rarer than generic refinement. ~75%.
Newly public, on-time 10-K, mgmt narrative incentive. Issuer-specific accounting complexity. Baseline 78-85% adjusted modestly down. ~78%.
Mgmt incentive + KPMG continuity + CFO buy. Material weakness is rare event in first 10-Q without prior signals. ~80%.
Per-10-Q late filing ~5%, material weakness ~3%, sale-leaseback escalation ~3-5% specific to Q1. Combined ~21%. NO ~21%, YES ~79%. ~79%.
Resolution Criteria
Resolves YES if EQPT files its Q1 2026 10-Q with the SEC by May 18, 2026 (3-business-day grace period over the standard 40-day deadline applicable to non-large accelerated filers) AND the filing contains no disclosure of material weakness in internal control over financial reporting AND no NT 10-Q (Form 12b-25) extension filing. Resolves NO if any of the following occur: (a) Form 12b-25 extension filed; (b) 10-Q filed after May 18, 2026; (c) management discloses material weakness in ICFR per Item 4 (Controls and Procedures) or KPMG identifies material weakness in any review-level communication disclosed in the filing.
Resolution Source
SEC EDGAR (10-Q filing); Item 4 Controls and Procedures disclosure
Source Trigger
First post-IPO 10-Q (Q1 2026) is the first quarterly disclosure under public-company timelines. Test of disclosure controls and segment reclassification or accounting refinement.
Full multi-lens equity analysis